Practice guidelines and professional autonomy in a universal health insurance system: The case of tissue plasminogen activator in Ontario
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Social Science & Medicine
- Vol. 31 (12) , 1327-1336
- https://doi.org/10.1016/0277-9536(90)90072-z
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Assessment of priority for coronary revascularisation proceduresThe Lancet, 1990
- Controlling Health Expenditures — the Canadian RealityNew England Journal of Medicine, 1989
- Medicine and the State in Canada: The Extra-Billing Issue in PerspectiveCanadian Journal Of Political Science-Revue Canadienne De Science Politique, 1988
- Initial sales of Genentech's TPA set new recordsNature, 1988
- A cost-effectiveness model for coronary thrombolysis/reperfusion therapyJournal of the American College of Cardiology, 1987
- Value of immediate coronary angioplasty following intracoronary thrombolysis in acute myocardial infarctionCatheterization and Cardiovascular Diagnosis, 1987
- Banning Extra-Billing in Canada: Just What the Doctor Didn't OrderCanadian Public Policy, 1987
- Percutaneous transluminal coronary angioplasty after thrombolytic therapy: A prospective controlled randomized trialJournal of the American College of Cardiology, 1986
- Is transluminal coronary angioplasty mandatory after successful thrombolysis? Quantitative coronary angiographic study.Heart, 1983
- New Developments in Medical-Surgical Treatment of Acute Myocardial InfarctionThe Annals of Thoracic Surgery, 1983